Metcalfe et al25 reported a 10-year risk of contralateral breast cancer of 43.4% for BRCA1 carriers and 34.6% for BRCA2 carriers who did not undergo oophorectomy or take tamoxifen. This evidence concerns the gene BRCA1 and breast carcinoma.